XML 83 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Cash flows from operating activities:          
Net loss from continuing operations     $ (46,357,000) $ (14,361,000)  
Adjustments to reconcile net loss from continuing operations to net cash used by operating activities:          
Depreciation and amortization     2,647,000 6,425,000  
Gain on allowance for obsolescence of inventory     (280,000)  
Stock based compensation     268,000 4,000  
Income on equity method investment     22,000 211,000  
(Gain) loss on investments     30,790,000 (3,823,000)  
Change in ROU assets     774,000 (10,202,000)  
Change in ROU liabilities     (1,052,000) 10,122,000  
Gain on extinguishment of debt $ (110,000) (110,000)  
Gain on sale of assets     (405,000)  
Impairment of notes receivable     3,757,000 1,745,000  
Decrease (increase) in assets:          
Accounts receivable     2,531,000 (460,000)  
Inventory     4,707,000 591,000  
Prepaid expenses and other current assets     592,000 1,307,000  
Other assets     3,123,000 (312,000)  
Increase (decrease) in liabilities:          
Accounts payable     (3,846,000) 192,000  
Accrued expenses     (15,958,000) (3,036,000)  
Other liabilities     (81,000) (373,000)  
Net cash used by operating activities - continuing operations     (18,083,000) (13,947,000)  
Net cash used by operating activities - held for sale     (1,632,000)  
Net cash used by operating activities     (19,715,000) (13,947,000)  
Cash flows from investing activities:          
Purchase of property, plant and equipment     (496,000) (976,000)  
Purchase of real estate     (689,000)  
Purchase of marketable securities     (4,805,000)  
Disposal of property, plant and equipment     215,000 2,557,000  
Sale of marketable securities     11,330,000  
Issuance of new notes receivable     (3,362,000)  
Payments received on notes receivable     2,327,000 863,000  
Net cash provided by (used in) investing activities     13,376,000 (6,412,000)  
Cash flows from financing activities:          
Payments of long-term debt     (5,519,000) (169,000)  
Borrowings of long-term debt     2,601,000 6,360,000  
Deferred financing fees      
Issuances of common stock, net of issuance costs     1,518,000  
Net cash (used in) provided by financing activities     (2,918,000) 7,709,000  
Net increase (decrease) in cash - continuing operations     (7,625,000) (12,650,000)  
Net increase (decrease) in cash – held for sale     (1,632,000)  
Cash and cash equivalents at beginning of period     19,290,000 56,595,000 $ 56,595,000
Cash and cash equivalents at end of period $ 10,033,000 $ 43,945,000 $ 10,033,000 $ 43,945,000 $ 19,290,000